Table 1.
Baseline characteristics
| PFA | CBA | RFA | P-value | |
|---|---|---|---|---|
| Baseline characteristics | ||||
| N | 40 | 80 | 80 | |
| Age [years] | 62.6 [56.3, 68.6] | 62.2 [54.7, 70.7] | 62.0 [55.4, 69.7] | 0.948 |
| Age > 65 years, n (%) | 18 (45.0) | 32 (40.0) | 33 (41.2) | 0.870 |
| Male sex, n (%) | 30 (75.0) | 58 (72.5) | 63 (78.8) | 0.653 |
| BMI [kg/m2] | 25.9 [23.2, 28.5] | 26.2 [24.0, 28.6] | 25.6 [23.6, 28.5] | 0.704 |
| Months since AF diagnosis [month] | 29.0 [8.0, 83.5] | 17.0 [5.0, 49.2] | 11.5 [3.0, 37.2] | 0.029 |
| CHA2DS2VASc score, n (%) | 0.417 | |||
| 0 | 10 (25.0) | 16 (20.0) | 16 (20.0) | |
| 1 | 5 (12.5) | 24 (30.0) | 17 (21.2) | |
| 2 | 12 (30.0) | 18 (22.5) | 22 (27.5) | |
| 3 | 8 (20.0) | 8 (10.0) | 17 (21.2) | |
| 4 | 3 (7.5) | 9 (11.2) | 6 (7.5) | |
| > 4 | 2 (5.0) | 5 (6.2) | 2 (2.5) | |
| Previous DCCV, n (%) | 4 (10.0) | 10 (12.5) | 15 (18.8) | 0.354 |
| Previous stroke or TIA, n (%) | 2 (5.0) | 4 (5.0) | 8 (10.0) | 0.398 |
| Coronary artery disease, n (%) | 8 (20.0) | 14 (17.5) | 10 (12.5) | 0.512 |
| Hypertension, n (%) | 26 (65.0) | 50 (62.5) | 48 (60.0) | 0.862 |
| Diabetes mellitus, n (%) | 3 (7.5) | 8 (10.0) | 9 (11.2) | 0.812 |
| Left atrial diameter [mm] | 42.0 [38.0, 45.8] | 42.0 [38.0, 45.0] | 41.0 [36.2, 45.8] | 0.799 |
| Left atrial volume index [mL/m2] | 38.0 [33.5, 45.2] | 37.3 [30.3, 46.0] | 37.0 [31.3, 44.5] | 0.699 |
| Left ventricular ejection fraction [%] | 60.0 [55.0, 60.0] | 60.0 [55.8, 65.0] | 60.0 [55.0, 60.0] | 0.419 |
Values are presented as median [IQR] or n (%). AF atrial fibrillation, BMI body mass index, CBA cryoballoon ablation, DCCV direct current cardioversion, IQR interquartile range, LVEF left ventricular ejection fraction, PFA pulsed-field ablation, RFA radiofrequency ablation, TIA transient ischemic attack